New low-affinity anti-CD19 CAR T cells exhibit peripheral expansion and persistence without inducing severe cytokine-response syndrome in pediatric patients with relapsed or refractory B cell acute lymphoblastic leukemia.
- Sara Ghorashian
- Anne Marijn Kramer
- Persis J. Amrolia
